Each 5ml syrup contains Prednisolone BP 10mg.
Excipients/Inactive Ingredients: Contains Sodium Benzoate as a preservative agent.
Walesolone is indicated for the treatment of Rheumatoid arthritis, Bronchial asthma and corticosteroid indicated conditions.
Dosages: Adult: 10 - 100mg daily in divided doses.
Acute infections, open-angle glaucoma, osteoporosis and cardiac disease.
Caution is required in patients with systemic sclerosis because of an increased incidence of (possibly fatal) scleroderma renal crisis with hypertension and decreased urinary output observed with a daily dose of 15mg or more prednisolone. Blood pressure and renal function (s-creatinine) should therefore be routinely checked. When renal crisis is suspected, blood pressure should be carefully controlled.
Walesolone contains aspartame, patients with phenylketonuria should avoid or limit usage of product.
Visual disturbance: Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
Use in Pregnancy: Animal studies indicate that prednisolone crosses the placenta and cause increased incidence of cleft palate, spontaneous abortions and retardation of foetal growth. It is not recommended for use in pregnancy unless the benefits outweigh the potential risk.
Use in Children: Chronic use in children may suppress growth and development of the child.
Usage in pregnancy: Animal studies indicate that prednisolone crosses the placenta and cause increased incidence of cleft palate, spontaneous abortions and retardation of foetal growth. It is not recommended for use in pregnancy unless the benefits outweigh the potential risk.
Vision, blurred.
Scleroderma renal crisis: Amongst the different subpopulations the occurrence of scleroderma renal crisis varies. The highest risk has been reported in patients with diffuse systemic sclerosis. The lowest risk has been reported in patients with limited systemic sclerosis (2%) and juvenile onset systemic sclerosis (1%). Fluids and salt retention, edema, hypertension, muscle weakness, increased appetite and growth retardation.
Efficacy may be reduced by phenytoin, phenobarbiturates and rifampicin.
Corticosteroids may reduce effect of diuretics and hypoglycaemics
Protect from light. Store in a cool, dry place not exceeding 30°C.
Further information can be obtained from the doctor or the pharmacist.
H02AB06 - prednisolone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.
Walesolone Syrup 10 mg/5 mL
100 mL x 1's;3.6 L x 1's
Sign Out
